康杏生醫股份有限公司

COMPANY PROFILE: 康杏生醫股份有限公司 (Kangxing Biomedical Co., Ltd.) LOCATION AND LEGAL STATUS 康杏生醫股份有限公司 is a Taiwan-registered company based in Taipei City. The company operates as a limited liability corporation under Taiwan's corporate structure. BUSINESS OPERATIONS The company is classified across multiple industry segments, including nutritional supplements, food and beverage, wholesale and retail distribution, health and pharmaceutical services, manufacturing and maintenance, and related service sectors. This broad categorization suggests the company may operate across several business lines or that its primary focus spans complementary healthcare and consumer product categories. The specific nature of the company's core business activities and its primary revenue streams are not clearly delineated in available data. CERTIFICATIONS AND COMPLIANCE 康杏生醫股份有限公司 holds a Certified V18 certification, which has been independently observed and documented by Reevol. Beyond this single verified certification, additional compliance credentials, regulatory approvals, or industry-specific certifications are not available in current records. PUBLIC FOOTPRINT AND TRANSPARENCY Reevol has not identified an active website or significant digital presence for this company. The company maintains a visibility score of 0, indicating minimal discernible online footprint or public-facing marketing materials. No participation in international trade fairs, documented export markets, or Harmonized System (HS) code classifications were identified. The company's founding year and employee count are not available. BUSINESS SCOPE CONSIDERATIONS The breadth of industry classifications—spanning from nutritional supplements to IT services to construction—may reflect either: (1) diverse business operations within a single corporate entity; (2) classification artifacts from business registry data; or (3) evolving service offerings. Buyers seeking to evaluate this supplier should seek direct clarification on the company's primary product lines and target markets. RECOMMENDATION FOR BUYERS Given the limited public information, companies considering engagement with 康杏生醫股份有限公司 should conduct direct due diligence, including verification of certifications, operational capacity, and specific product or service offerings. The lack of documented export activity or trade participation suggests either a domestically focused business model or limited international visibility. Prospective partners should request detailed company documentation, production capabilities, quality assurance protocols, and references before establishing commercial relationships.